Xiamen Amoytop Biotech Co Ltd Cash Flow Quality Index
Xiamen Amoytop Biotech Co Ltd cash flow quality index. Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow Quality Index of 1.99x as of September 2023. Operating cash flow of CN¥332.29 Million exceeds net income of CN¥166.73 Million, indicating high earnings quality where cash backs reported profits. See Xiamen Amoytop Biotech Co Ltd (688278) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Xiamen Amoytop Biotech Co Ltd (2016–2024)
Cash flow quality index of Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. Historical Cash Flow Quality Index for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Xiamen Amoytop Biotech Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Xiamen Amoytop Biotech Co Ltd Cash Flow Quality Index by Year (2016–2024)
Xiamen Amoytop Biotech Co Ltd cash flow quality index by year from 2016 to 2024. Year-by-year earnings quality comparison for Xiamen Amoytop Biotech Co Ltd. For the full cash flow conversion analysis, see Xiamen Amoytop Biotech Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | CN¥430.63 Million | CN¥827.60 Million | ▼ -43.6% |
| 2023 | 0.92x | CN¥512.10 Million | CN¥555.45 Million | ▼ -27.1% |
| 2022 | 1.27x | CN¥363.16 Million | CN¥287.02 Million | ▼ -2.3% |
| 2021 | 1.30x | CN¥234.78 Million | CN¥181.26 Million | ▲ +62.7% |
| 2020 | 0.80x | CN¥92.61 Million | CN¥116.35 Million | ▼ -58.5% |
| 2019 | 1.92x | CN¥123.30 Million | CN¥64.29 Million | ▼ -65.6% |
| 2018 | 5.57x | CN¥89.15 Million | CN¥16.00 Million | ▲ +352.4% |
| 2017 | -2.21x | CN¥-11.41 Million | CN¥5.17 Million | ▼ -252.5% |
| 2016 | 1.45x | CN¥42.43 Million | CN¥29.31 Million | — |